Ajanta Pharma - Investments In Branded Generics Added Certainty, Scalability, Sustainability: Dolat Capital
3 weeks ago•Bloomberg Quint
Ajanta Pharma Q3 Results Review - Asia, Africa Drive Earnings: Motilal Oswal
5 months ago•Bloomberg Quint
India Pharma - IPM Growth On Moderate Uptrend In September: Motilal Oswal
9 months ago•Bloomberg Quint
Pharma Key Molecule Check - Traction In Key Dr. Reddy’s, Lupin, Ajanta Pharma Products: Yes Securities
9 months ago•Bloomberg Quint
Ajanta Pharma Shares At All-Time High After August Sales Data
10 months ago•Bloomberg Quint
Stocks In Focus | Zomato, Sula, BHEL, RVNL, Ajanta Pharma & More | BQ Prime
10 months ago•Bloomberg Quint
Buy Ajanta Pharma; target of Rs 1580: ICICI Securities
11 months ago•Moneycontrol